ACE2 and COVID-19: Sensory deficits associated with COVID-19 have been observed in both the acute and post-acute phases, and one study has demonstrated that adult human inner ear tissue cells coexpress the angiotensin-converting enzyme 2 (ACE2) receptor and cofactors required for SARS-CoV-2 virus entry (19).